Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMM GROUP LIMITED Share Issue/Capital Change 2016

Feb 7, 2016

65078_rns_2016-02-07_6426bdb7-b37c-4b5a-8e7f-339e6a0b3dc7.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

AUSTRALIAN SECURITIES EXCHANGE ANNOUNCEMENT FLEXIGROUP LIMITED ("FXL")

Sydney, 8 February 2016

CHANGES IN LTIP OPTIONS AND PERFORMANCE RIGHTS

FlexiGroup Limited advises that it has increased the number of options and performance rights on issue by 467,372 instruments. The net increase is as a result of the issue of 1,161,000 performance rights, exercise of 404,053 performance rights and options and lapse of 289,575 performance rights and options.

As at 8 February 2016, FlexiGroup Limited has 4,497,455 options and performance rights outstanding.

Wyall-Anduson

Company Secretary

PH: 02 8905 7526

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, $04/03/13$

Name of entity

FlexiGroup Limited

ABN

$\overline{2}$

75 122 574 583

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\mathbf 1$ +Class of +securities issued or to be issued

Number of +securities issued or

Performance rights over Ordinary Shares issued under the FlexiGroup Long Term Incentive Plan

  • 1,161,000
  • to be issued (if known) or maximum number which may be issued
  • Principal of the terms 3 *securities (e.g. if options, exercise price and expiry date; if +securities, partly paid the amount outstanding and due dates for payment; if +convertible securities. the conversion price and dates for conversion)

Performance Rights issued pursuant to the FlexiGroup Long Term Incentive Plan with an exercise price of \$0.00 per performance right with expiry dates of 15 October 2018, 15 October 2019 and 15 October 2021

+ See chapter 19 for defined terms.

$\tilde{\mathbf{C}}$

$\overline{4}$ Do the + securities rank equally
in all respects from the + issue
date with an existing + class of
quoted +securities?
N/A
If the additional + securities do
not rank equally, please state:
the date from which they do
۰
the extent to which they
for the
participate
next
dividend, (in the case of a
distribution)
trust,
or
interest payment
the extent to which they do
not rank equally, other than
relation to the
in
next
dividend,
distribution
or
interest payment
5 Issue price or consideration Nil issue price per Performance Right
Nil exercise price per Performance Right
6 Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
Performance Rights issued in accordance
with the FlexiGroup Long Term Incentive
Plan
6a Is the entity an + eligible entity
that has obtained security
holder approval under rule 7.1A?
If Yes, complete sections 6b - 6h
in relation to the + securities the
No
subject of this Appendix 3B, and
comply with section 6i
6b The date the security holder
resolution under rule 7.1A was
passed
N/A
Number of + securities issued
without security holder approval
under rule 7.1
N/A

+ See chapter 19 for defined terms.

  • 6d Number of $\pm$ securities issued $N/A$ with security holder approval under rule 7.1A
  • 6e Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)
  • 6f Number of +securities issued under an exception in rule 7.2
  • $N/A$ 6g If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.
  • 6h If +securities were issued under $N/A$ rule $7.1A$ for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements
  • Calculate the entity's remaining $N/A$ 6i issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

$\overline{7}$ +Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

8 Number and +class of all *securities quoted on ASX $(including$ the $+{\rm securities}$ in section 2 if applicable)

Number + Class
372,351,650 Fully paid ordinary
shares

$N/A$

$N/A$

26 November 2015

  • See chapter 19 for defined terms.

Number and +class of all 9 +securities not quoted on ASX (including the +securities in section 2 if applicable)

Number + Class
4,497,455 Options and
Performance Rights
over Shares

Dividend policy (in the case of a $10\,$ trust, distribution policy) on the increased capital (interests)

No change

Part 2 - Pro rata issue

11 security holder
approval
Is
required?
12 Is the issue renounceable or non-
renounceable?
13 Ratio in which the + securities
will be offered
14 + Class of + securities to which the
offer relates
15 +Record date
determine
to
entitlements
16 different
Will
holdings
on
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17 Policy for deciding entitlements
in relation to fractions
18 Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing date for receipt
of
acceptances or renunciations

Names of any underwriters $20$ Amount of any underwriting fee $21$ or commission Names of any brokers to the $2.2$ issue Fee or commission payable to $23$ the broker to the issue Amount of any handling fee $24$ payable to brokers who lodge acceptances or renunciations on behalf of security holders If the issue is contingent on $25$ security holders' approval, the date of the meeting Date entitlement and acceptance $26$ form and offer documents will be sent to persons entitled If the entity has issued options, $27$ and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders Date rights trading will begin (if $28$ applicable) Date rights trading will end (if 29 applicable) How do security holders sell 30 their entitlements in full through a broker? How do security holders sell part 31 of their entitlements through a broker and accept for the balance?

Appendix 3B Page 5

+ See chapter 19 for defined terms.

  • How do security holders dispose $32$ of their entitlements (except by sale through a broker)?
  • +Issue date 33

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

Type of +securities 34 (tick one)

$(a)$

$(b)$

  • *Securities described in Part 1
  • All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or
documents
  • If the *securities are *equity securities, the names of the 20 largest holders of the 35 additional +securities, and the number and percentage of additional +securities held by those holders
  • 36 If the *securities are *equity securities, a distribution schedule of the additional *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ 5,001 - 10,000 10,001 - 100,000 100,001 and over
  • A copy of any trust deed for the additional +securities 37

+ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

  • 38 Number of +securit +quotation is sought
  • +Class of +securitio 39 quotation is sought
  • Do the +securities rank equally in 40 all respects from the +issue date with an existing +class of quoted +securities?

If the additional +securities do not rank equally, please state:

  • the date from which they do
  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution interest or payment
  • Reason for request for quotation $41$ now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another +security, clearly identify that other +security)

Number and $+$ class $\circ$ f all $42$ quoted on ASX +securities (including the +securities in clause $38)$

Number + Class
1 DOX 34(D)
ties for which
t
es for which

+ See chapter 19 for defined terms.

Quotation agreement

  • +Quotation of our additional +securities is in ASX's absolute discretion. ASX $\mathbf{I}$ may quote the +securities on any conditions it decides.
  • We warrant the following to ASX. $\overline{2}$
  • The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
  • There is no reason why those +securities should not be granted $\bullet$ +quotation.
  • An offer of the 'securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any 'securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the 'securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the $\bullet$ *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the 'securities be quoted.
  • We will indemnify ASX to the fullest extent permitted by law in respect of any $\overline{\mathbf{3}}$ claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any $\overline{4}$ information or document is not available now, we will give it to ASX before *quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

Mall- AndWJO ~...........Date: 8 February 2016 Company secretary

Print name:

Julianne Lyall-Anderson

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

+ See chapter 19 for defined terms.

Appendix 3B - Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid +ordinary
securities on issue 12 months before the
*issue date or date of agreement to issue
Add the following:
Number of fully paid +ordinary securities
issued in that 12 month period under an
exception in rule 7.2
Number of fully paid +ordinary securities
$\bullet$
issued in that 12 month period with
shareholder approval
Number of partly paid +ordinary
$\bullet$
securities that became fully paid in that
12 month period
Note:
Include only ordinary securities here -
other classes of equity securities cannot
be added
Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
$\bullet$
securities on different dates as separate
line items
Subtract the number of fully paid +ordinary
securities cancelled during that 12 month
period
"A"

+ See chapter 19 for defined terms.

Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be changed]
Multiply "A" by 0.15
that has already been used Step 3: Calculate "C", the amount of placement capacity under rule 7.1
Insert number of + equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
Under an exception in rule 7.2
Under rule 7.1A
$\bullet$
With security holder approval under rule
7.1 or rule 7.4
Note:
This applies to equity securities, unless
specifically excluded - not just ordinary
securities
Include here (if applicable) the securities
۰
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
$\bullet$
securities on different dates as separate
line items
"C"
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
"A" $\times$ 0.15
Note: number must be same as shown in
Step 2
Subtract "C"
Note: number must be same as shown in
Step 3
Total ["A" $\times$ 0.15] - "C"
[Note: this is the remaining placement
capacity under rule 7.1]

+ See chapter 19 for defined terms.

Part 2

Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be changed
Multiply "A" by 0.10
Step 3: Calculate "E", the amount of placement capacity under rule
7.1A that has already been used
Insert number of + equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
This applies to equity securities - not
just ordinary securities
Include here $-$ if applicable $-$ the
$\bullet$
securities the subject of the Appendix
3B to which this form is annexed
Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
It may be useful to set out issues of
$\bullet$
securities on different dates as separate
line items
"E"

+ See chapter 19 for defined terms.

$\overline{a}$

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
"A" $\times$ 0.10
Note: number must be same as shown in
Step 2
Subtract "E"
Note: number must be same as shown in
Step 3
Total ["A" $\times$ 0.10] – "E"
Note: this is the remaining placement
capacity under rule 7.1A

+ See chapter 19 for defined terms.